Company Filing History:
Years Active: 2024
Title: Pinglei Liu: Innovator in Immunotherapy
Introduction
Pinglei Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunotherapy, particularly through his innovative research and development of specific antibodies.
Latest Patents
Pinglei Liu holds a patent for an anti-human MSLN antibody and MSLN-targeting immune effector cell. This invention provides an anti-human MSLN-specific antibody and an MSLN-targeting immune effector cell. Additionally, it includes an MSLN-targeting chimeric antigen receptor modified T-cell prepared using the antibody and its various uses. He has 1 patent to his name.
Career Highlights
Pinglei Liu is associated with Hrain Biotechnology Co., Ltd., where he continues to advance his research in the field of biotechnology. His work focuses on developing innovative solutions for cancer treatment through targeted immunotherapy.
Collaborations
Pinglei Liu collaborates with notable colleagues, including Fei Huang and Tao Peng, who contribute to his research endeavors.
Conclusion
Pinglei Liu's work in developing MSLN-targeting therapies showcases his commitment to advancing medical science. His contributions are paving the way for new treatments in immunotherapy.